Please assess the completion status of the following clinical trial:

Trial Title: A Randomized Study to Evaluate a Novel Method of Specific Allergen Immunotherapy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion criteria:~* Written informed consent~* History of allergic rhino-conjunctivitis in spring and summer~* Age 18 years to 65 years~* Positive skin prick test to grass pollen~Exclusion criteria:~* Blood donation within previous 30 days~* Surgery within the previous 30 days~* Use of investigational drugs within previous 90 days~* Pregnancy or nursing~* Mastocytosis~* Significant cardiovascular disease~* Hypertension~* Active infectious disease~* Significant hepatic disease~* Significant renal disease~* Significant hematological disorder~* Significant pulmonary disease~* Moderate or severe asthma~* Autoimmune disease~* History of malignancy.~* Contraindicated medications were immunosuppressive agents, beta-blockers, ACE-inhibitors, and tricyclic antidepressants.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).